ADS Biosystems Inc.
San Diego, USA
|
ADS Biosystems Inc. focuses on cancer and metabolic diseases. The company has established state-of-art platforms for early cancer detection with new cancer markers. ADS has also been working on potential therapeutics against SARS-CoV-2. The company's quantitative ELISA kit detects RBD binding antibodies against RBD domain of spike protein of SARS-CoV-2 and has been verified with 31 recovered COVID-19 patients and healthy controls.